Life Technologies Acquires Advanced Microscopy Group

AMG provides Life Technologies with a complete set of imaging products ranging across of a large range of functionality and prices. In addition, it establishes a foundation for new product innovation in fluorescent and bright field imaging devices. Data on financial terms of the deal are not being disclosed. AMG's existing business will remain in Bothell, Washington, and will join Life Technologies' Flow Cytometry and Imaging business unit.

AMG has a portfolio of imaging instruments that spans basic to advanced microscopy. The EVOS range of instruments improves ease of use by eliminating conventional eyepieces and replacing them with liquid crystal display (LCD) screens. Two entry-level microscopes, EVOS XL and EVOS XL-Core, address the tissue culture market for routine monitoring of cell culture through measurements of cell density and morphology. The instruments are bright field and phase contrast-enabled and come with a range of magnification lens options. The EVOS FL is a multicolor fluorescent microscope with bright field/phase contrast capabilities and a range of objective options.

"Our acquisition of Advanced Microscopy Group brings together two leaders in the cell imaging field," said Peter Dansky, president of Molecular and Cell Biology at Life Technologies. "With AMG's demonstrated excellence in innovative microscopy instrumentation and the Molecular Probes line of market leading imaging reagents, we're now better able to serve our customers with a complete portfolio of integrated solutions for cell analysis optimized for performance and ease of use."

The microscopy market size is estimated to be approximately USD 770 million. AMG's existing business will remain in the state of Washington (USA), and will join Life Technologies ' Flow Cytometry and Imaging business unit.

Related Links:
Life Technologies
Advanced Microscopy Group